• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bio-Rad Laboratories (NY: BIO )

    293.85 -1.88 (-0.64%)
    Official Closing Price Updated: 7:00 PM EDT, May 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 189,761
    Open 296.00
    Bid (Size) 265.80 (1)
    Ask (Size) 307.66 (1)
    Prev. Close 295.73
    Today's Range 290.86 - 296.00
    52wk Range 261.59 - 431.79
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
    Via Benzinga
    BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024
    BIO stock results show that Bio-Rad Laboratories beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -10.41%
    -10.41%
    1 Month
    +5.05%
    +5.05%
    3 Month
    -14.52%
    -14.52%
    6 Month
    -3.50%
    -3.50%
    1 Year
    -24.10%
    -24.10%

    More News

    Read More
    Bio-Rad Reports First-Quarter 2024 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad Laboratories: Q4 Earnings Insights
    Via Benzinga
    Earnings Scheduled For February 15, 2024
    Via Benzinga
    Preview: Bio-Rad Laboratories's Earnings
    Via Benzinga
    Earnings Outlook For Bio-Rad Laboratories
    Via Benzinga
    Bio-Rad Announces Life Science Group Management Changes
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad’s Chief Operating Officer Andrew Last to Retire
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
    Via Benzinga
    Topics Artificial Intelligence Economy Stocks
    Exposures Artificial Intelligence Interest Rates US Equities
    Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today?
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Bio-Rad Reports Third-Quarter 2023 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.